Đang chuẩn bị liên kết để tải về tài liệu:
A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Ramucirumab has recently proved to be effective for advanced or recurrent gastric cancer (AGC). Ascites and peritoneal metastasis are among the most common complications of AGC. | A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites

TÀI LIỆU LIÊN QUAN

A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites

Evaluation of efficacy and safety of percutaneous transforaminal endoscopic surgery (PTES) for surgical treatment of calcified lumbar disc herniation: A retrospective cohort study of 101 patients

The efficacy and safety of tranexamic acid for reducing blood loss following simultaneous bilateral total knee arthroplasty: A multicenter retrospective study

The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: A retrospective study

A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: Clinical efficacy and safety

Acute stroke treatment and outcome in the oldest old (90years and older) at a tertiary care medical centre in Germany-a retrospective study showing safety and efficacy in this particular patient population

Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: A retrospective cohort study

Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: A retrospective analysis of the CELESTIAL randomised controlled trial

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: A retrospective study

Efficacy and safety of concurrent antiCancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: A retrospective study
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.